Danny L. Dearen's most recent trade in Beta Bionics Inc. was a trade of 11,247 Common Stock done . Disclosure was reported to the exchange on March 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beta Bionics Inc. | Danny L. Dearen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 49.44 per share. | 26 May 2023 | 7,699 | 9,502 (0%) | 0% | 49.4 | 380,604 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 50.14 per share. | 26 May 2023 | 300 | 9,202 (0%) | 0% | 50.1 | 15,042 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2023 | 13,208 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 21 Apr 2023 | 13,208 | 37,201 (0%) | 0% | 14.2 | 187,422 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 59.93 per share. | 21 Apr 2023 | 10,363 | 26,838 (0%) | 0% | 59.9 | 621,063 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 60.50 per share. | 21 Apr 2023 | 9,637 | 17,201 (0%) | 0% | 60.5 | 583,074 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 60.01 per share. | 20 Apr 2023 | 2,001 | 23,993 (0%) | 0% | 60.0 | 120,073 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Apr 2023 | 2,001 | 13,208 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 20 Apr 2023 | 2,001 | 25,994 (0%) | 0% | 14.2 | 28,394 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 55.68 per share. | 31 Mar 2023 | 7,802 | 23,993 (0%) | 0% | 55.7 | 434,404 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 54.83 per share. | 31 Mar 2023 | 7,198 | 31,795 (0%) | 0% | 54.8 | 394,699 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 6,633 | 15,209 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 31 Mar 2023 | 6,633 | 30,626 (0%) | 0% | 14.2 | 94,122 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 5,468 | 7,032 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.82 per share. | 31 Mar 2023 | 5,468 | 36,094 (0%) | 0% | 25.8 | 141,184 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 31 Mar 2023 | 2,899 | 38,993 (0%) | 0% | 1.6 | 4,725 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 2,899 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 25,250 | 37,750 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 20,000 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 15,000 | 15,000 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 61.17 per share. | 31 Jan 2023 | 7,791 | 29,959 (0%) | 0% | 61.2 | 476,571 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 5,250 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 5,000 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 5,000 | 5,000 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 61.02 per share. | 31 Jan 2023 | 2,772 | 23,993 (0%) | 0% | 61.0 | 169,136 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 31 Jan 2023 | 2,720 | 27,239 (0%) | 0% | 61.1 | 166,252 | Common Stock |
| Axonics Inc | Danny L. Dearen | President & CFO | Sale of securities on an exchange or to another person at price $ 60.43 per share. | 31 Jan 2023 | 474 | 26,765 (0%) | 0% | 60.4 | 28,646 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 75.60 per share. | 13 Sep 2022 | 656 | 7,500 (0%) | 0% | 75.6 | 49,594 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 70.33 per share. | 11 Aug 2022 | 26,760 | 31,396 (0%) | 0% | 70.3 | 1,881,921 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 11 Aug 2022 | 20,545 | 44,859 (0%) | 0% | 1.6 | 33,488 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 20,545 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 71.26 per share. | 11 Aug 2022 | 16,280 | 15,116 (0%) | 0% | 71.3 | 1,160,173 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 11 Aug 2022 | 7,047 | 51,906 (0%) | 0% | 14.2 | 99,997 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 7,047 | 2,223 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 72.19 per share. | 11 Aug 2022 | 6,960 | 8,156 (0%) | 0% | 72.2 | 502,429 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.82 per share. | 11 Aug 2022 | 6,250 | 58,156 (0%) | 0% | 25.8 | 161,375 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 6,250 | 12,500 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 11 Aug 2022 | 2,044 | 24,314 (0%) | 0% | 1.3 | 2,698 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 2,044 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 11 Aug 2022 | 1,616 | 22,270 (0%) | 0% | 1.3 | 2,133 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2022 | 1,616 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 12,329 | 2,343 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.82 per share. | 01 Mar 2022 | 12,329 | 40,564 (0%) | 0% | 25.8 | 318,335 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 58.11 per share. | 01 Mar 2022 | 10,564 | 20,654 (0%) | 0% | 58.1 | 613,913 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 57.39 per share. | 01 Mar 2022 | 7,846 | 31,218 (0%) | 0% | 57.4 | 450,321 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 56.32 per share. | 01 Mar 2022 | 1,500 | 39,064 (0%) | 0% | 56.3 | 84,475 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 25 Feb 2022 | 10,000 | 28,235 (0%) | 0% | 57 | 570,000 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 6,421 | 14,672 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.82 per share. | 25 Feb 2022 | 6,421 | 34,656 (0%) | 0% | 25.8 | 165,790 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,579 | 6,666 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 25 Feb 2022 | 3,579 | 38,235 (0%) | 0% | 14.2 | 50,786 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 36,919 | 46,919 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 26,086 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 31 Jan 2022 | 20,000 | 30,000 (0%) | 0% | 14.2 | 283,800 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 20,000 | 32,468 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 48.21 per share. | 31 Jan 2022 | 17,737 | 29,182 (0%) | 0% | 48.2 | 855,106 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 49.07 per share. | 31 Jan 2022 | 13,853 | 10,400 (0%) | 0% | 49.1 | 679,718 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 11,000 | 21,000 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 10,833 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 5,250 | 5,250 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 5,250 | 5,250 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 48.26 per share. | 31 Jan 2022 | 3,730 | 24,253 (0%) | 0% | 48.3 | 179,999 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 46.83 per share. | 31 Jan 2022 | 2,017 | 27,983 (0%) | 0% | 46.8 | 94,452 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 49.03 per share. | 31 Jan 2022 | 947 | 28,235 (0%) | 0% | 49.0 | 46,436 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 49.70 per share. | 31 Jan 2022 | 400 | 10,000 (0%) | 0% | 49.7 | 19,878 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 18 Jan 2022 | 10,805 | 20,805 (0%) | 0% | 14.2 | 153,323 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 10,805 | 52,468 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 50.80 per share. | 18 Jan 2022 | 9,756 | 15,932 (0%) | 0% | 50.8 | 495,648 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 5,477 | 23,444 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 18 Jan 2022 | 5,477 | 26,282 (0%) | 0% | 1.6 | 8,928 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 49.73 per share. | 18 Jan 2022 | 4,312 | 25,688 (0%) | 0% | 49.7 | 214,428 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 51.68 per share. | 18 Jan 2022 | 3,886 | 12,046 (0%) | 0% | 51.7 | 200,832 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 3,718 | 0 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 18 Jan 2022 | 3,718 | 30,000 (0%) | 0% | 1.4 | 5,280 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 52.61 per share. | 18 Jan 2022 | 2,046 | 10,000 (0%) | 0% | 52.6 | 107,632 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 20 May 2021 | 28,291 | 38,291 (0%) | 0% | 14.2 | 401,449 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 28,291 | 63,273 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 55.05 per share. | 20 May 2021 | 24,618 | 10,000 (0%) | 0% | 55.0 | 1,355,135 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 54.45 per share. | 20 May 2021 | 18,516 | 34,618 (0%) | 0% | 54.5 | 1,008,265 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 20 May 2021 | 9,701 | 47,992 (0%) | 0% | 1.3 | 12,805 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 9,701 | 1,616 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 55.22 per share. | 20 May 2021 | 6,866 | 10,000 (0%) | 0% | 55.2 | 379,164 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 5,875 | 28,921 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 20 May 2021 | 5,875 | 16,866 (0%) | 0% | 1.6 | 9,576 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 20 May 2021 | 5,142 | 53,134 (0%) | 0% | 1.3 | 6,787 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 5,142 | 11,925 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 20 May 2021 | 991 | 10,991 (0%) | 0% | 1.3 | 1,308 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 991 | 10,934 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2021 | 16,000 | 90,993 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 10,833 | 10,833 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 10,000 | 74,993 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 10,000 | 10,000 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2021 | 8,000 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 51.36 per share. | 31 Jan 2021 | 6,751 | 84,242 (0%) | 0% | 51.4 | 346,762 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 52.12 per share. | 31 Jan 2021 | 507 | 83,735 (0%) | 0% | 52.1 | 26,424 | Common Stock |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 13,043 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Danny L. Dearen | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 13,043 | 69,534 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Danny L. Dearen | See Remarks | Sale of securities on an exchange or to another person at price $ 53.58 per share. | 26 Jan 2021 | 4,541 | 64,993 (0%) | 0% | 53.6 | 243,291 | Common Stock |